BioSyntech Retains Leading Investor Relations Firm.LAVAL, Canada -- BioSyntech, Inc. ("BioSyntech" or "the Company") (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension VENTURE:BSY BSY Busy BSY British School of Yoga BSY Bit Sync BSY Busy Line ) today announced that it has retained the Equicom Group Inc. ("Equicom") to provide the Company with strategic investor relations Investor relations The process by which the corporation communicates with its investors. and financial communications services. Equicom provides strategic communications services to more than 70 Canadian public companies across a diverse range of industries. BioSyntech will pay Equicom a monthly retainer fee of $6,000 for professional services (job) professional services - A department of a supplier providing consultancy and programming manpower for the supplier's products. . The initial contract term is for twelve months. Neither Equicom nor any of its principals has an ownership interest, directly or indirectly, in BioSyntech or its securities, and the Company has not granted Equicom or its principals any right to acquire such an interest. The principals of Equicom are: Barry Hildred, President; Jason Hogan, Executive Vice President; Scott Kelly, Senior Vice President, Creative Services Creative Services are a subsector of the creative industries, a part of the economy that creates wealth by offering creativity for hire to other businesses. Examples include:
About BioSyntech BioSyntech is a biotechnology company specializing in the discovery, development and manufacturing of innovative cost-effective and physician-friendly therapeutic thermogels for regenerative medicine and therapeutic delivery. BioSyntech's Quality Management System is registered to ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 9001:2000 standards. BioSyntech is listed on the TSX Venture Exchange TSX Venture Exchange Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors. , Canada. For additional information, visit www.biosyntech.com. About Equicom Headquartered in Toronto, with an office in Montreal, the Equicom Group is Canada's leading Investor Relations consulting firm. With proven expertise in developing and executing highly effective strategic communications programs, and an extensive network of investment community contacts, Equicom specializes in helping clients achieve their capital markets objectives. Equicom offers a comprehensive suite of services including: investor relations, media relations, annual report production, multimedia and web design, web casting, live event management and corporate branding. For further information, please visit www.equicomgroup.com. NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. BioSyntech Inc. (TSX VENTURE:BSY) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion